超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

GE Healthcare Biacore   
Biocore（Stockholm Stock Exchange Symbol：BCOR）是瑞典醫療器械著名的制造廠商，位于瑞典Uppsala，主要銷售生物醫學和藥物研發中蛋白-蛋白相互作用儀器和分析試劑。整合Biocore的資源將幫助GE Healthcare拓寬蛋白研究工具的市場產品覆蓋。

紐約2006年6月20日的消息，通用電氣醫療集團（GE Healthcare）通過其下屬部門GE Medical Holding AB宣布將以約瑞典克朗SEK29億（美元3億9千萬），收購Biacore International以擴充其蛋白研究領域。

GE Healthcare的CEO Joe Hogan表示“生物科學對于GE而言是一個重要的組成部門，而Biocore可以高度的補充和配合我們目前的蛋白科學產品，因此此次收購可以延伸GE診斷和早期治療領域。”

這一交易將以每股SEK330的Biacore收購開始，預期在7月10日至8月10日完成商討，Biacore董事局（包括最大的股東輝瑞(Pfizer)）已接收這一報價。
   
Label-free interaction analysis is of increasing importance for scientists in the academic, pharmaceutical, biotechnology and diagnostic markets. Setting the performance benchmark, Biacore systems generate unique data on the interactions between proteins and other molecules, including small molecule drug candidates. During research, development and manufacture, these data give insights into protein functionality, elucidate disease mechanisms and play a key role in the critical decisions needed for efficient development and production of therapeutics.

Biacore systems are used in areas such as pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture, and many life science research applications. A range of systems meet specific application needs. Customers include leading research centers, all of the leading global pharmaceutical companies, and many biotechnology companies.

In the food analysis market, a system and ready-to-use kits provide key manufacturers with the ability to determine quality and safety in areas such as quantification of vitamin content and screening for veterinary drug residues.